Moderna+2026+JPM+Presentation_1.9.26_FINAL+for+web+upload-78-.pdf

1、 2026 Moderna,Inc.All rights reserved.44thAnnual J.P.Morgan Healthcare ConferenceJanuary 12,2026 2026 Moderna,Inc.All rights reserved.J.P.Morgan Healthcare Conference 2026Forward-looking statements and disclaimerThis presentation contains forward-looking statements within the meaning of the Private

2、Securities Litigation Reform Act of 1995,as amended,including statements regarding:Modernas projected commercial and financial performance;Modernas 2026 financial framework,including projected up to 10%revenue growth and reduced costs;Modernas ability to execute on further cash costs reductions;Mode

3、rnas targeted cash breakeven in 2028;the impact of Modernas multi-year partnerships;expected strong uptake of mNEXSPIKE in 2026 and expansion into new markets;Modernas ability to launch new infectious disease products and advance its oncology pipeline;Modernas commercial growth drivers in 2027 and 2

4、028,including geographic expansion and potential new products;expected market sizes;anticipated 2026 clinical milestones milestones;and the potential and timing for future data readouts,product approvals and commercial launches.The forward-looking statements in this presentation are neither promises

5、 nor guarantees,and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks,uncertainties,and other factors,many of which are beyond Modernas control and which could cause actual results to differ materially from those expressed or implied

6、 by these forward-looking statements.These risks,uncertainties,and other factors include those other risks and uncertainties described under the heading“Risk Factors”in Modernas Annual Report on Form 10-K for the fiscal year ended December 31,2024,filed with the U.S.Securities and Exchange Commissio